969 related articles for article (PubMed ID: 21098710)
1. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
[TBL] [Abstract][Full Text] [Related]
3. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
5. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J
J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
[TBL] [Abstract][Full Text] [Related]
8. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
9. [Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings].
Tong GD; Zhou DQ; He JS; Xiao CL; Liu XL; Zhou XZ; Zhang X; Xing YF; Lü P; Feitelson MA
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):828-32. PubMed ID: 18073065
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
11. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
12. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
13. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
15. Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Liu T; Xue R; Dong L; Wu H; Zhang D; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):45-51. PubMed ID: 21138899
[TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
19. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
